M.D. Anderson Cancer Center: all 3,044 studies

Page 24 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological MalignanciesTerminatedNCT01630564Phase 1
• Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung CancerActive, not recruitingNCT01629498Phase 1/2
• Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton TherapyActive, not recruitingNCT01627093
• Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and RadiationWithdrawnNCT01627080
• Imaging Study Compare 4DCT ImageCompletedNCT01626001Phase 1
• Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced CancersCompletedNCT01624766Phase 1
• NK Cells in Cord Blood TransplantationStatus unknownNCT01619761Phase 1
• Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant SurvivorsActive, not recruitingNCT01608152
• Study of Curcumin, Vorinostat, and SorafenibWithdrawnNCT01608139Phase 1
• Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the CervixStatus unknownNCT01606293
• A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive WomenCompletedNCT01605656
• Preventing Sexual Dysfunction With Aromatase InhibitorsCompletedNCT01603303Phase 2
• Systemic Therapy With Interferon, Interleukin-2 and BRAF InhibitorCompletedNCT01603212Phase 1
• Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced CancerCompletedNCT01596140Phase 1
• Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain MetastasesActive, not recruitingNCT01592968Phase 3
• EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid TumorsActive, not recruitingNCT01591356Phase 1
• Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaCompletedNCT01590732Phase 1
• Aerosolized Aldesleukin in Treating Patients With Lung MetastasesActive, not recruitingNCT01590069Phase 1/2
• Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT01562301Phase 1
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
• Prospective Trial of Metformin - Chemoprevention RoleWithdrawnNCT01550900Not applicable
• Pazopanib or Pemetrexed and Crizotinib in Advanced CancerTerminatedNCT01548144Phase 1
• Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung CancerCompletedNCT01540552
• Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)CompletedNCT01539343Phase 2
• Erlotinib in Combination With Pralatrexate in Advanced MalignanciesCompletedNCT01532011Phase 1
• Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF MutationsCompletedNCT01531361Phase 1
• Temsirolimus in Combination With Metformin in Patients With Advanced CancersTerminatedNCT01529593Phase 1
• BiPAP-Vapotherm RCTWithdrawnNCT01518140Phase 2
• Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) TrialActive, not recruitingNCT01512589Phase 2
• Lifestyle Intervention for High Risk Cancer SurvivorsCompletedNCT01508273Not applicable
• Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid OverloadWithdrawnNCT01508260Not applicable
• Reducing Cancer Disparities Among Latinos in TexasCompletedNCT01504919Not applicable
• Part II: Exercise in Hispanic Breast Cancer SurvivorsActive, not recruitingNCT01504789Not applicable
• Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
• Data Collection of Normal Tissue Toxicity for Proton Therapy for PediatricsStatus unknownNCT01502150
• Infusion of Allogeneic CD19-Specific T Cells From Peripheral BloodCompletedNCT01497184Phase 1
• R-21 Colorectal Cancer Screening (CRCS) Pilot TrialCompletedNCT01492049Not applicable
• Determinants of Multiple Health Risk Behaviors Among LatinosStatus unknownNCT01479257
• Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on TrastuzumabWithdrawnNCT01479179Phase 1/2
• Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular LymphomaActive, not recruitingNCT01473628Phase 1/2
• Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesCompletedNCT01471067Phase 1
• Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)CompletedNCT01469247Phase 1/2
• The Role of the EKG in Anticancer Drug DevelopmentCompletedNCT01462383
• Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)CompletedNCT01460498Phase 1
• Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid TumorsCompletedNCT01454804Phase 1
• The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)Status unknownNCT01447199
• Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking MenCompletedNCT01447186
• Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)Active, not recruitingNCT01446133Phase 2
• Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) PatientsCompletedNCT01440582Phase 1
• Juice Plus+ and Juice Plus+ Complete in Ovarian CancerActive, not recruitingNCT01439659Phase 2
• Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous BypassCompletedNCT01433302
• Objective Assessment of Technical Skills in Cardiothoracic SurgeryCompletedNCT01433029
• Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck CancerCompletedNCT01432132
• Phase 1 Trial With SIR-Spheres and Cetuximab +/- ErlotinibWithdrawnNCT01432119Phase 1
• Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss PatientsCompletedNCT01430572Phase 1
• Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation TherapyTerminatedNCT01430351Phase 1
• Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT01427205Phase 2
• Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic LeukemiaActive, not recruitingNCT01424982Phase 2
• Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid MalignanciesCompletedNCT01421173Phase 1
• Temsirolimus In Phase 0CompletedNCT01417065Early Phase 1
• TEST: Registry for Endoscopic Head and Neck SurgeryTerminatedNCT01412749
• Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation TherapyActive, not recruitingNCT01410942Phase 2
• Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node MetastasisCompletedNCT01409200Phase 2
• IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic MelanomaWithdrawnNCT01409187Phase 1/2
• IPI Biochemotherapy for Chemonaive Patients With Metastatic MelanomaTerminatedNCT01409174Phase 1
• Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced LeukemiasCompletedNCT01396499Phase 1
• Phase II Evaluation of Exhaled Nitric Oxide (NO)CompletedNCT01392144
• End of Life Treatment Preferences of Latino Medicare Beneficiaries With CancerStatus unknownNCT01389830
• Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaCompletedNCT01372540Phase 1
• Clearance Of Mucus In Stents (COMIS)CompletedNCT01370278Not applicable
• Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T CellsCompletedNCT01362452Phase 1
• SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)Active, not recruitingNCT01352520Phase 2
• Open-Label Study of TPI 287 for Patients With Metastatic MelanomaWithdrawnNCT01340729Phase 1/2
• Study of Pazopanib and Vorinostat in Patients With Advanced MalignanciesCompletedNCT01339871Phase 1
• Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast CancerActive, not recruitingNCT01334021Phase 2
• Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)WithdrawnNCT01333423Phase 1
• 18-F-Fluoroacetate as PET Imaging AgentWithdrawnNCT01320787Phase 1
• Study of 18F-Fluoro-PEG6-IPQACompletedNCT01320059Phase 1
• Diabetic Treatment AdherenceCompletedNCT01318564
• Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer SurvivorsStatus unknownNCT01311856
• Social Determinants and Smoking CessationCompletedNCT01310842
• Virtual Reality Intervention in Cancer GeneticsWithdrawnNCT01310829
• In Vivo Dosimetry During Prostate Cancer RadiotherapyCompletedNCT01307852Phase 1
• Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT01301807Phase 1
• Nuclear and Near-Infrared (NIR) Imaging in MelanomaCompletedNCT01295931Phase 1
• Cidofovir Versus Best Supportive Care for Hemorrhagic CystitisActive, not recruitingNCT01295645Phase 2
• Obesity: Cancer Risk Among African AmericansStatus unknownNCT01294657
• Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic PainActive, not recruitingNCT01278225
• Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the PancreasTerminatedNCT01276613Early Phase 1
• Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)WithdrawnNCT01270893Phase 2
• Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma PatientsWithdrawnNCT01269203Phase 2
• Sirolimus or Vorinostat and Hydroxychloroquine in Advanced CancerCompletedNCT01266057Phase 1
• Controlled Trial Of Acupuncture To Prevent Radiation-Induced XerostomiaActive, not recruitingNCT01266044Phase 3
• A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and ObesityTerminatedNCT01262664Phase 1
• Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord CompressionCompletedNCT01256554Phase 1
• Delayed-Delayed Breast ReconstructionCompletedNCT01256528Not applicable
• Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC)Active, not recruitingNCT01254903Phase 1
• Radiation Therapy in Treating Patients With Stage 0-II Breast CancerActive, not recruitingNCT01245712Phase 2
• Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) ScrambleActive, not recruitingNCT01224288Phase 3
• Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2

← M.D. Anderson Cancer Center overview and focus areas